Evidence map›Paper›PMID 18234728›Full record

ReviewJournal of medical genetics2008

BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.

J R Toro, M-H Wei, G M Glenn, M Weinreich, O Toure, C Vocke, M Turner, P Choyke, M J Merino, P A Pinto and 3 more

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of medical genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02916992 (Prevalence of Birt-Hogg-Dubé Syndrome Among Patients With), which is not on this map. Cited by 205 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 4 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02916992 phase1unknown statusnot on this mapstarted 2016, after this paper: background citation

Prevalence of Birt-Hogg-Dubé Syndrome Among Patients With (Hereditary) Spontaneous Pneumothorax

TypeinterventionalSponsorHans SmitRan2016 to 2017Enrolled200ConditionsSpontaneous PneumothoraxArmsCT scan of the thorax, blood sample for FLCN mutation analyses
3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 4 syntheses or guidelines pooled it, 512 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Genes & diseases · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Thyroid Carcinoma in Birt-Hogg-Dubé Syndrome: Case Series and Review of Literature.Thyroid : official journal of the American Thyroid Association · 2025
    Review
  19. Review
  20. Article

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

J R ToroGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Executive Plaza South, Room 7012, Rockville, MD 20892-7231, USA. torojo@mail.nih.gov
M-H Wei
G M Glenn
M Weinreich
O Toure
C Vocke
M Turner
P Choyke
M J Merino
P A Pinto
S M Steinberg
L S Schmidt
W M Linehan
Center for Cancer Research · USNational Cancer Institute · USNational Institutes of Health · USScience Applications International Corporation (United States) · US

Funding

Molecular Therapeutics of Kidney Cancer: MET Gene and BHD GeneZIABC011043 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2009 to 2025
$20.9M
Clinical Studies of the Molecular Genetic Basis of Kidney CancerZIABC011028 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2009 to 2025
$17.9M
STUDIES OF PERSONS AT HIGH RISK OF CANCER--GENETIC EPIDEMIOLOGYZ01CP004410 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI TUCKER, MARGARET · 1985 to 2008
$15.0M
Tissue ProcessingSequencing FacilityZICBC011044 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI VOCKE, CATHY D · 2009 to 2025
$13.5M
Clinical Fellowship Training ProgramZIEBC011023 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PINTO, PETER · 2009 to 2025
$10.3M
TUMOR SUPPRESSOR GENES IN GENITOURINARY MALIGNANCYZ01SC006659 · SC · CLINICAL SCIENCES · PI LINEHAN, WILLIAM MARSTON · 1996 to 2007
$4.0M
BIOSTATISTICS AND DATA MANAGEMENT SECTIONZ01SC007202 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI STEINBERG, SETH M · 1996 to 2008
$1.5M
Clinical Nursing and Data Management CoreZ01BC011089 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2008 to 2008
$855k
Study of Hereditary Renal SyndromesZ01BC010696 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MERINO NEUMANN, MARIA · 2005 to 2008
$697k
STRUCTURE AND STABILIZATION OF THE BACTERIAL NUCLEOIDZ01DK036120 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI ZIMMERMAN, STEVEN C. · 1998 to 2005
–
Intramural NIH HHS Z01 SC006659NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400.
6 · The paper itself

Abstract

backgroundBirt-Hogg-Dubé syndrome (BHDS) (MIM 135150) is an autosomal dominant predisposition to the development of follicular hamartomas (fibrofolliculomas), lung cysts, spontaneous pneumothorax, and kidney neoplasms. Germline mutations in BHD are associated with the susceptibility for BHDS. We previously described 51 BHDS families with BHD germline mutations.

objectiveTo characterise the BHD mutation spectrum, novel mutations and new clinical features of one previously reported and 50 new families with BHDS.

methodsDirect bidirectional DNA sequencing was used to screen for mutations in the BHD gene, and insertion and deletion mutations were confirmed by subcloning. We analysed evolutionary conservation of folliculin by comparing human against the orthologous sequences.

resultsThe BHD mutation detection rate was 88% (51/58). Of the 23 different germline mutations identified, 13 were novel consisting of: four splice site, three deletions, two insertions, two nonsense, one deletion/insertion, and one missense mutation. We report the first germline missense mutation in BHD c.1978A>G (K508R) in a patient who presented with bilateral multifocal renal oncocytomas. This mutation occurs in a highly conserved amino acid in folliculin. 10% (5/51) of the families had individuals without histologically confirmed fibrofolliculomas. Of 44 families ascertained on the basis of skin lesions, 18 (41%) had kidney tumours. Patients with a germline BHD mutation and family history of kidney cancer had a statistically significantly increased probability of developing renal tumours compared to patients without a positive family history (p = 0.0032). Similarly, patients with a BHD germline mutation and family history of spontaneous pneumothorax had a significantly increased greater probability of having spontaneous pneumothorax than BHDS patients without a family history of spontaneous pneumothorax (p = 0.011). A comprehensive review of published reports of cases with BHD germline mutation is discussed.

conclusionBHDS is characterised by a spectrum of mutations, and clinical heterogeneity both among and within families.

Indexed as

Amino Acid SequenceBase SequenceDNA Mutational AnalysisFamilyFemaleGenotypeGerm-Line MutationHumansMaleMolecular Sequence DataMutation, MissenseNeoplastic Syndromes, HereditaryPedigreePhenotypeProto-Oncogene ProteinsTumor Suppressor ProteinsFLCN protein, humanProto-Oncogene ProteinsTumor Suppressor Proteins

Identifiers

PMID18234728
PMCPMC2564862
OpenAlexW2107960245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.